Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma

Activation of the activator protein 1 (AP‐1) transcription factor as well as increased serum levels of vascular endothelial growth factor (VEGF) and interleukin (IL)‐8 predict poor prognosis of patients with hepatocellular carcinomas (HCCs). Moreover, HCC patients display reduced selenium levels, which may cause lipid peroxidation and oxidative stress because selenium is an essential component of antioxidative glutathione peroxidases (GPx). We hypothesized that selenium‐lipid peroxide antagonism controls the above prognostic markers and tumor growth. (1) In human HCC cell lines (HCC‐1.2, HCC‐3, and SNU398) linoleic acid peroxide (LOOH) and other prooxidants enhanced the expression of VEGF and IL‐8. LOOH up‐regulated AP‐1 activation. Selenium inhibited these effects. This inhibition was mediated by glutathione peroxidase 4 (GPx4), which preferentially degrades lipid peroxides. Selenium enhanced GPx4 expression and total GPx activity, while knock‐down of GPx4 by small interfering RNA (siRNA) increased VEGF, and IL‐8 expression. (2) These results were confirmed in a rat hepatocarcinogenesis model. Selenium treatment during tumor promotion increased hepatic GPx4 expression and reduced the expression of VEGF and of the AP‐1 component c‐fos as well as nodule growth. (3) In HCC patients, increased levels of LOOH‐related antibodies (LOOH‐Ab) were found, suggesting enhanced LOOH formation. LOOH‐Ab correlated with serum VEGF and IL‐8 and with AP‐1 activation in HCC tissue. In contrast, selenium inversely correlated with VEGF, IL‐8, and HCC size (the latter only for tumors smaller than 3 cm). Conclusion: Reduced selenium levels result in accumulation of lipid peroxides. This leads to enhanced AP‐1 activation and consequently to elevated expression of VEGF and IL‐8, which accelerate the growth of HCC. Selenium supplementation could be considered for investigation as a strategy for chemoprevention or additional therapy of early HCC in patients with low selenium levels. (HEPATOLOGY 2012)

[1]  F. Hucke,et al.  Clinical characteristics of patients with hepatocellular carcinoma in Austria – is there a need for a structured screening program? , 2011, Wiener klinische Wochenschrift.

[2]  B. Aggarwal,et al.  Oxidative stress, inflammation, and cancer: how are they linked? , 2010, Free radical biology & medicine.

[3]  M. Sturm,et al.  Impact of selenite and selenate on differentially expressed genes in rat liver examined by microarray analysis. , 2010, Bioscience reports.

[4]  G. Beckett,et al.  Selenium supplementation attenuates procollagen-1 and interleukin-8 production in fat-loaded human C3A hepatoblastoma cells treated with TGFbeta1. , 2010, Biochimica et biophysica acta.

[5]  R. Goldbohm,et al.  Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. , 2010, Gastroenterology.

[6]  S. Harrison,et al.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.

[7]  S. Toppo,et al.  Catalytic mechanisms and specificities of glutathione peroxidases: variations of a basic scheme. , 2009, Biochimica et biophysica acta.

[8]  R. Brigelius-Flohé,et al.  Glutathione peroxidases in different stages of carcinogenesis. , 2009, Biochimica et biophysica acta.

[9]  M. Mitterhauser,et al.  Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated rats. , 2009, Journal of hepatology.

[10]  J. Crowley,et al.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). , 2009, JAMA.

[11]  R. Schulte‐Hermann,et al.  HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis. , 2008, Journal of hepatology.

[12]  C. Cotton,et al.  Dysfunction of Nrf-2 in CF Epithelia Leads to Excess Intracellular H2O2 and Inflammatory Cytokine Production , 2008, PloS one.

[13]  J. Stamler,et al.  Redox-based regulation of signal transduction: principles, pitfalls, and promises. , 2008, Free radical biology & medicine.

[14]  C. Pirker,et al.  New cellular tools reveal complex epithelial–mesenchymal interactions in hepatocarcinogenesis , 2008, British Journal of Cancer.

[15]  R. Schulte‐Hermann,et al.  Lipid hydroperoxides from processed dietary oils enhance growth of hepatocarcinoma cells. , 2008, Molecular nutrition & food research.

[16]  A. Siddiqui,et al.  Hepatitis C Virus Stabilizes Hypoxia-Inducible Factor 1α and Stimulates the Synthesis of Vascular Endothelial Growth Factor , 2007, Journal of Virology.

[17]  G. Bellomo,et al.  Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti‐coagulant activity , 2007, Clinical and experimental immunology.

[18]  I. Rusyn,et al.  Predictive Power of Biomarkers of Oxidative Stress and Inflammation in Patients with Hepatitis C Virus-Associated Hepatocellular Carcinoma , 2007, Annals of Surgical Oncology.

[19]  K. Schmid,et al.  Mammalian Target of Rapamycin Pathway Activity in Hepatocellular Carcinomas of Patients Undergoing Liver Transplantation , 2007, Transplantation.

[20]  M. Kaito,et al.  Increased lipid peroxidation in patients with non‐alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8‐isoprostane , 2006, Journal of gastroenterology and hepatology.

[21]  G. Sumara,et al.  c-Jun/AP-1 controls liver regeneration by repressing p53/p21 and p38 MAPK activity. , 2006, Genes & development.

[22]  S. Thorgeirsson,et al.  A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells , 2006, Nature Medicine.

[23]  R. Hayes,et al.  High Serum Selenium and Reduced Risk of Advanced Colorectal Adenoma in a Colorectal Cancer Early Detection Program , 2006, Cancer Epidemiology Biomarkers & Prevention.

[24]  M. Vidali,et al.  Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis , 2005, Gut.

[25]  R. Schulte‐Hermann,et al.  Dietary lipid hydroperoxides induce expression of vascular endothelial growth factor (VEGF) in human colorectal tumor cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  A. Podhajska,et al.  Gene transfer of CuZn superoxide dismutase enhances the synthesis of vascular endothelial growth factor , 2004, Molecular and Cellular Biochemistry.

[27]  O. Barbash,et al.  Expression of Angiogenic Factors Vascular Endothelial Growth Factor and Interleukin-8/CXCL8 Is Highly Responsive to Ambient Glutamine Availability , 2004, Cancer Research.

[28]  E. Larsen,et al.  Selenium prevents tumor development in a rat model for chemical carcinogenesis. , 2004, Carcinogenesis.

[29]  D. Bar-Sagi,et al.  Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.

[30]  S. Fan,et al.  Interleukin-8 serum levels in patients with hepatocellular carcinoma: correlations with clinicopathological features and prognosis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  J. Filep,et al.  Selenium-containing compounds attenuate peroxynitrite-mediated NF-kappaB and AP-1 activation and interleukin-8 gene and protein expression in human leukocytes. , 2003, Free radical biology & medicine.

[32]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[33]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[34]  V. Cipriani,et al.  Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C , 2003, Hepatology.

[35]  B. Turnbull,et al.  Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: an analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial , 2003, BJU international.

[36]  E. Wagner,et al.  Liver Tumor Development c-Jun Antagonizes the Proapoptotic Activity of p53 , 2003, Cell.

[37]  S. Fan,et al.  Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  S. Fan,et al.  Serum Vascular Endothelial Growth Factor Predicts Venous Invasion in Hepatocellular Carcinoma : A Prospective Study , 2001, Annals of surgery.

[39]  R. Tangirala,et al.  Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E. , 2001, Blood.

[40]  Cheng Jiang,et al.  Monomethyl selenium–specific inhibition of MMP‐2 and VEGF expression: Implications for angiogenic switch regulation , 2000, Molecular carcinogenesis.

[41]  K. Stolze,et al.  Spin trapping of lipid radicals with DEPMPO-derived spin traps: detection of superoxide, alkyl and alkoxyl radicals in aqueous and lipid phase. , 2000, Free radical biology & medicine.

[42]  Cheng Jiang,et al.  Selenium‐induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake , 1999, Molecular carcinogenesis.

[43]  R. Brigelius-Flohé.  Tissue-specific functions of individual glutathione peroxidases. , 1999, Free radical biology & medicine.

[44]  C. J. Chen,et al.  Plasma selenium levels and risk of hepatocellular carcinoma among men with chronic hepatitis virus infection. , 1999, American journal of epidemiology.

[45]  E. Rimm,et al.  Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. , 1998, Journal of the National Cancer Institute.

[46]  I. Hyodo,et al.  Circulating vascular endothelial growth factor (VEGF) is a possible tumor marker for metastasis in human hepatocellular carcinoma , 1998, Journal of Gastroenterology.

[47]  E. Constant,et al.  Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. , 1998 .

[48]  T. Osawa,et al.  Characterization of a specific polyclonal antibody against 13-hydroperoxyoctadecadienoic acid-modified protein: formation of lipid hydroperoxide-modified apoB-100 in oxidized LDL. , 1997, Journal of lipid research.

[49]  Bruce W. Turnbull,et al.  Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin: A Randomized Controlled Trial , 1996 .

[50]  G. Spyrou,et al.  AP‐1 DNA‐binding activity is inhibited by selenite and selenodiglutathione , 1995, FEBS letters.

[51]  A. deFazio,et al.  Inhibition of AP-1 binding and transcription by gold and selenium involving conserved cysteine residues in Jun and Fos. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[52]  E. Wagner,et al.  c-Jun is essential for normal mouse development and hepatogenesis , 1993, Nature.

[53]  K. Yasumoto,et al.  Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. , 1992, The Journal of biological chemistry.

[54]  P. Cerutti,et al.  Mechanism of c-fos induction by active oxygen. , 1992, Cancer research.

[55]  P. R. Lyons,et al.  Differential regulation of rat liver selenoprotein mRNAs in selenium deficiency. , 1992, Biochemical and biophysical research communications.

[56]  J. Fiddes,et al.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.

[57]  S. Ylä-Herttuala,et al.  Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. , 1990, Arteriosclerosis.

[58]  W. Li,et al.  Selenium chemoprevention of liver cancer in animals and possible human applications , 2008, Biological Trace Element Research.

[59]  Sung-Hoon Kim,et al.  Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density , 2008, International journal of cancer.

[60]  Wen Li,et al.  Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong , 2007, Biological Trace Element Research.

[61]  A. Siddiqui,et al.  Hepatitis C virus stabilizes hypoxia-inducible factor 1alpha and stimulates the synthesis of vascular endothelial growth factor. , 2007, Journal of virology.

[62]  H. Ganther,et al.  New Concepts in Selenium Chemoprevention , 2004, Cancer and Metastasis Reviews.

[63]  Chih-Ping Chen,et al.  Prognostic Significance of Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Angiogenin in Patients With Resectable Hepatocellular Carcinoma After Surgery , 2003, Annals of Surgical Oncology.

[64]  V. Cipriani,et al.  Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. , 2002, Free radical biology & medicine.

[65]  B W Turnbull,et al.  Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. , 1996, JAMA.

[66]  L. Flohé,et al.  Assays of glutathione peroxidase. , 1984, Methods in enzymology.